Shandong Sinobioway Biomedicine Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 191.021 million compared to CNY 434.430 million a year ago. Operating loss was CNY 121.593 million compared to operating Income of CNY 60.776 million a year ago. Net loss was CNY 105.994 million compared to net income of CNY 49.319 million a year ago. Basic loss per share from continuing operations was CNY 0.1607 compared to basic earnings per share from continuing operations of CNY 0.0748 a year ago.